NEW YORK, Aug. 7, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds Uroplasty, Inc. (Nasdaq:UPI) investors of the important August 30, 2013 deadline in the class action brought on behalf of those who purchased Uroplasty stock between July 26, 2012 and June 13, 2013, inclusive.
To join the Uroplasty class action, visit the firm's website at http://rosenlegal.com, or call Phillip Kim, Esq. or Kevin Chan, toll-free, at 866-767-3653; you may also email at pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The lawsuit claims that Uroplasty materially misstated and/or failed to disclose that it (1) improperly recorded revenue; (2) made improper sales commission payments; (3) lacked adequate internal and financial controls; and (4) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times. According to the lawsuit, when the market learned of these adverse facts the price of Uroplasty stock dropped, damaging investors.
If you wish to serve as lead plaintiff, you must move the Court no later than August 30, 2013. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at pkim@rosenlegal.com. You may also visit the firm's website at http://rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.